Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis

<h4>Objective</h4> <p>To characterize the early disease course in childhood-onset antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) and the 12-month outcomes in children with AAV.</p> <h4>Methods</h4> <p>Eligible subjects were children...

Full description

Bibliographic Details
Main Authors:	Morishita, K, Moorthy, L, Lubieniecka, J, Twilt, M, Yeung, R, Toth, M, Shenoi, S, Ristic, G, Nielsen, S, Luqmani, R, Li, S, Lee, T, Lawson, E, Kostik, M, Klein-Gitelman, M, Huber, A, Hersh, A, Foell, D, Elder, M, Eberhard, B, Dancey, P, Charuvanij, S, Benseler, S, Cabral, D
Format:	Journal article
Language:	English
Published:	Wiley 2017

Similar Items

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
by: Mukhtyar, C, et al.
Published: (2006)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
by: Mukhtyar, C, et al.
Published: (2008)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
by: Flossmann, O, et al.
Published: (2006)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
by: Talks, S, et al.
Published: (1994)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis
by: Chand, S, et al.
Published: (2013)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
by: Robson, J, et al.
Published: (2017)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
by: Walsh, M, et al.
Published: (2011)

Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
by: Jayne, DR, et al.
Published: (1997)

Goodpasture's syndrome with antineutrophil cytoplasmic antibodies
by: Losada, E, et al.
Published: (1993)

Antineutrophil cytoplasmic antibodies in autoimmune hepatitis.
by: Bansi, D, et al.
Published: (1995)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
by: De Groot, K, et al.
Published: (2005)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
by: Mukhtyar, C, et al.
Published: (2008)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
by: de Groot, K, et al.
Published: (2009)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
by: Robson, J, et al.
Published: (2013)

S100A12 serum levels and PMN counts are elevated in childhood systemic vasculitides especially involving proteinase 3 specific anti-neutrophil cytoplasmic antibodies
by: Brown, K, et al.
Published: (2018)

Characterisation of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis
by: Cameron, B, et al.
Published: (1998)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AFTER LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS
by: Bansi, D, et al.
Published: (1995)

Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
by: Bansi, D, et al.
Published: (1996)

Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
by: Harper, L, et al.
Published: (2004)

IGG SUBCLASS DISTRIBUTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
by: Bansi, D, et al.
Published: (1995)

Assessing ACR/EULAR provisional 2017 classification criteria for granulomatosis with polyangiitis (GPA) in a cohort of 376 children with small to medium vessel chronic vasculitis - a pediatric vasculitis initiative (PedVas) study
by: Rivera, A, et al.
Published: (2017)

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
by: Bansi, D, et al.
Published: (1997)

Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
by: Bansi, D, et al.
Published: (1996)

Detection of antineutrophil cytoplasmic antibody in primary sclerosing cholangitis: Comparison of the alkaline phosphatase and immunofluorescent techniques.
by: Bansi, D, et al.
Published: (1996)

DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PRIMARY SCLEROSING CHOLANGITIS - COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES
by: Bansi, D, et al.
Published: (1995)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES ARE ABSENT IN UNAFFECTED RELATIVES OF PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
by: Bansi, D, et al.
Published: (1995)

Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
by: Bansi, D, et al.
Published: (1996)

Characterization of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis (PSC) ulcerative colitis (UC).
by: Cameron, B, et al.
Published: (1998)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODY TITER BUT NOT IGG SUBCLASS DISTINGUISHES BETWEEN PRIMARY SCLEROSING CHOLANGITIS AND AUTOIMMUNE HEPATITIS
by: Bans, D, et al.
Published: (1995)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
by: Guerry, M, et al.
Published: (2012)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
by: Basu, N, et al.
Published: (2014)

Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
by: Bansi, D, et al.
Published: (1996)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
by: Robson, J, et al.
Published: (2017)

Disease activity assessment in childhood vasculitis: Development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS)
by: Dolezalova, P, et al.
Published: (2013)

Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).
by: Dolezalova, P, et al.
Published: (2013)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
by: Hellmich, B, et al.
Published: (2007)

The UK & Ireland Vasculitis Registry (UKIVAS): Cross-sectional data on the first 2290 Patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV)
by: Luqmani, R, et al.
Published: (2017)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
by: Luqmani, R, et al.
Published: (2017)

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
by: Merkel, P, et al.
Published: (2009)

ANTINEUTROPHIL ANTIBODY AND PRIMARY SCLEROSING CHOLANGITIS
by: Lo, S, et al.
Published: (1991)